An open label multi facilities cooperation randomized control trial for prevention Evolution of Diabetic nephrOpathy by Olmesarta
Not Applicable
Recruiting
- Conditions
- Hypertensive type2 diabetic patients without nephropathy
- Registration Number
- JPRN-UMIN000002718
- Lead Sponsor
- Jyoto Hypertension Research Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
SBP >=160mgHg or DBP >=100mgHg. Secondary hypertension Severe hepatic dysfunction or renal damage. Severe adverse effects with study drugs. Severs clincal condition due to tumors et al. Inappropriate cases based on the descision by responsible doctors .
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method